Nanologica presents at Redeye Theme: Diabetes 23 May
Nanologica’s CEO Andreas Bhagwani will present the company at Redeye Theme: Diabetes on 23 May at 11.10. Link to follow the event
Nanologica’s CEO Andreas Bhagwani will present the company at Redeye Theme: Diabetes on 23 May at 11.10. Link to follow the event
Nanologica AB (publ) today 16 May 2024 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition of result The Annual General Meeting adopted the income statement and balance sheet for the company and the group in accordance with the presented accounting documents and resolved, in accordance with the board´s proposal, that the accumulated loss of SEK -75,880,232 shall be carried forward.
Vd Andreas Bhagwani kommenterar Nanologicas kvartalsrapport för första kvartalet 2024.
The annual report in Swedish and a translation in English is available on www.nanologica.com in a pdf format. The official original version of the annual report is prepared in Swedish in the European Single Electronic Format (ESEF). Swedish: https://nanologica.com/category/finansiella-rapporter/ English translation: https://nanologica.com/category/financial-reports/
The subscription period for shares in Nanologica´s rights issue has now started. For information on how to subscribe, please see below links: Swedish: https://nanologica.com/foretradesemission-2024/ English: https://nanologica.com/rights-issue-2024/ Subscription period: 28 Feb – 13 Mar 2024 Subscription price: SEK 6.75
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SINGAPORE, SYDAFRIKA, ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDET, PUBLICERINGEN ELLER DISTRIBUTIONEN AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG, VARA FÖREMÅL FÖR LEGALA RESTRIKTIONER ELLER SKULLE KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER. Nanologica AB (publ) (”Nanologica” eller ”Bolaget”) offentliggör prospekt med anledning av den företrädesemission av aktier motsvarande cirka 54,2 MSEK som beslutades av styrelsen den 30 januari